Advertisement

Contesting the Obesity ‘Epidemic’: Elements of a Counter Discourse

  • Henk van den BeltEmail author
Chapter
Part of the The International Library of Environmental, Agricultural and Food Ethics book series (LEAF, volume 18)

Abstract

In Chapter 3 of this volume, Tsjalling Swierstra distinguishes three discourses, all agreeing that obesity constitutes a pressing problem but each focusing on different causes of and solutions to this problem. Discourse I emphasizes the significance of personal behaviour, which is seen as under the individual’s control; discourse II highlights the causal role of the environment, while discourse III puts the burden on the biological peculiarities of the human body. In this chapter I will discuss yet another discourse that stands orthogonal to the three discourses distinguished by Swierstra. As it challenges the dominant belief, shared by these three discourses, that the increasing prevalence of overweight and obesity constitutes a serious public health problem, it can appropriately be called a ‘counter discourse’.

Keywords

Primary Pulmonary Hypertension Obese Person Obesity Research Internal Revenue Service Diet Pill 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abenhaim, L., Y. Moride, F. Brenot et al. (1996), Appetite-suppressant drugs and the risk of primary pulmonary hypertension, New England Journal of Medicine, 335, 609–616CrossRefGoogle Scholar
  2. Allison, D.B., K.R. Fontaine, J.E. Manson, J. Stevens and T.B. VanItallie (1999), Annual deaths attributable to obesity in the United States, JAMA, 282, 1530–1538CrossRefGoogle Scholar
  3. American Obesity Association (2003), Obesity is a chronic disease http://www.obesity.org/treatment/obesity.shtml
  4. Angell, M. and J.P. Kassirer (1996), Editorial: Editorials and conflicts of interest, New England Journal of Medicine, 335, 1055–1056CrossRefGoogle Scholar
  5. Angell, M. and A.S. Relman. (2002), Patents, profits & American medicine: conflicts of interest in the testing & marketing of new drugs, Daedalus, 131, 102–111Google Scholar
  6. Associated Press (2002), IRS Recognizes Obesity as Disease Google Scholar
  7. Associated Press (2004), Fat activists protest diet industry, CNN.com Google Scholar
  8. Austin, S.B. (1999), Fat, loathing and public health: The complicity of science in a culture of disordered eating, Culture, Medicine and Psychiatry, 23, 245–268CrossRefGoogle Scholar
  9. Blair, S.N. and T.S. Church (2004), The fitness, obesity, and health equation: Is physical activity the common denominator? JAMA, 292, 1232–1234CrossRefGoogle Scholar
  10. Borbély, M. (2001), Is obesity a disease? The Government says yes – until it’s time to pay for treatment, Washington Post Google Scholar
  11. Bray, G.A. (2004), Obesity is a chronic, relapsing neurochemical disease, International Journal of Obesity, 28, 34–38CrossRefGoogle Scholar
  12. Brennan, P. (2002), Feds mull obesity as ‘disease’ – you’ll pay billions, NewsMax.com Google Scholar
  13. CNN.com (1996), Anti-obesity drug to get warning. http://www.cnn.com/HEALTH/9608/22/weight.drug
  14. Calle, E.E., C. Rodriguez, K. Walker-Thurmond and M.J. Thun (2003), Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US, Adults, New England Journal of Medicine, 348, 1625–1638CrossRefGoogle Scholar
  15. Campos, P. (2004), The Obesity Myth: Why America’s Obsession with Weight is Hazardous to Your Health. New York, NY: Gotham BooksGoogle Scholar
  16. Campos, P., A. Saguy, P. Ernsberger, E. Oliver and G. Gaesser (2006), The epidemiology of overweight and obesity: Public health crisis or moral panic? International Journal of Epidemiology, 35, 55–60CrossRefGoogle Scholar
  17. Canguilhem, G. (1978), On the Normal and the Pathological. Dordrecht: ReidelGoogle Scholar
  18. Center for Consumer Freedom (2004), An Epidemic of Obesity Myths. Washington, DC: Center for Consumer FreedomGoogle Scholar
  19. Center for Science in the Public Interest. (2003), Lifting the Veil of Secrecy: Corporate Support for Health and Environmental Professional Associations, Charities, and Industry Front Groups. Washington, DC: Center for Science in the Public InterestGoogle Scholar
  20. Chang, V.W. and N.A. Christakis (2002), Medical modelling of obesity: A transition from action to experience in a 20th century American medical textbook, Sociology of Health & Illness, 24, 151–177CrossRefGoogle Scholar
  21. Couzin, J. (2005), A heavyweight battle over CDC’s obesity forecasts, Science, 308, 770–771Google Scholar
  22. Ernsberger, P. and R.J. Koletsky (1999), Biomedical rationale for a wellness approach to obesity: An alternative to a focus on weight loss, Journal of Social Issues, 55, 221–260CrossRefGoogle Scholar
  23. Flegal, K.M. et al. (2005), Excess deaths associated with underweight, overweight, and obesity, JAMA, 293, 1861–1873CrossRefGoogle Scholar
  24. Flegal, K.M., D.F. Williamson, E.R. Pamuk and H.M. Rosenberg (2004), Estimating deaths attributable to obesity in the United States, American Journal of Public Health, 94, 1486–1489CrossRefGoogle Scholar
  25. Fontaine, K.R., D.T. Redden, C. Wang, A.O. Westfall and D.B. Allison. (2003), Years of Life Lost Due to Obesity, JAMA, 289, 187–193CrossRefGoogle Scholar
  26. Fraser, L. (1998), Losing It: False Hopes and Fat Profits in the Diet Industry. New York, NY: Plume BooksGoogle Scholar
  27. Fumento, M. (2000), Don’t Buy the “Fat Gene” Myth, The New York Post. http://www.fumento.com/julyfat.html
  28. Fumento, M. (2002), Quick living in the fat lane, Rocky Mountain News. http://www.fumento.com/fatlane.html
  29. Fumento, M. (2004), Medicare help obesity? Fat chance, Scripps Howard News Service. http://www.fumento.com/fat/obesity.html
  30. Gaesser, G.A. (2003), Is it necessary to be thin to be healthy? Harvard Health Policy Review, 4, 2, 40–47Google Scholar
  31. Ginnis, J.M. and W.H. Foege (1993), Actual causes of death in the United States, JAMA, 270, 2207–2212CrossRefGoogle Scholar
  32. Hajer, M. (2003), Discourse coalitions and institutionalisation of practice: The case of acid rain in Great Britain, In: Fischer F. and J. Forester (eds), The Argumentative Turn in Policy Analysis and Planning. London: UCL Press, 43–76Google Scholar
  33. Harris, P. (2004), Fat is fabulous, insist anti-diet protesters. The Observer Google Scholar
  34. Healy, D. (2004), Shaping the intimate: Influences on the experience of everyday nerves, Social Studies of Science, 34, 2, 219–245CrossRefGoogle Scholar
  35. Heshka, S. and D.B. Allison (2001), Is obesity a disease? International Journal of Obesity, 25, 1401–1404CrossRefGoogle Scholar
  36. Horton, R. (1997), Commentary: Conflicts of interest in clinical research: Opprobrium or obsession? The Lancet, 349, 1112–1113CrossRefGoogle Scholar
  37. Horton, R. (2004), The dawn of mcscience, New York Review of Books, 51, 4Google Scholar
  38. Jeurissen, E. and M. van Spanje (2001), Rondom dik: Zin en onzin over zwaarlijvigheid. Amsterdam: AmboGoogle Scholar
  39. Klein, R. and M. Fumento (1997), Dialogues: Fat. http://www.slate.com/id/3667/entry/24016 [Accessed October 2010]
  40. Krimsky, S. (1999), The profit of scientific discovery and its normative implications, Chicago-Kent Law Review, 75, 15–39Google Scholar
  41. Krimsky, S. (2003), Science and the Private Interest. Lanham, MD: Rowman-LittlefieldGoogle Scholar
  42. Krimsky, S. (2005), The funding effect in science and its implications for the judiciary, Journal of Law and Policy, 13, 43–68Google Scholar
  43. Lexchin, J., L.A. Bero, B. Djulbegovic and O. Clark (2003), Pharmaceutical industry sponsorship and research outcome and quality: Systematic review, BMJ (British Medical Journal), 326, 1167–1179CrossRefGoogle Scholar
  44. Liebman, A. (2003), Producer’s Notebook: Spin Doctors, Frontline: Dangerous Pre-scription. http://www.pbs.org/wgbh/pages/frontline/shows/prescription/etc/notebook.html [Accessed July 2005]
  45. Manson, J.E. (1997), Adventures in scientific discourse, Epidemiology, 8, 324–327Google Scholar
  46. Manson, J.E. and S.S. Bassuk (2003), Obesity in the United States: A fresh look at its high toll, JAMA, 289, 229–230CrossRefGoogle Scholar
  47. Manson, J.E. and G.A. Faich (1996a), Editorial: Pharmacotherapy for obesity – do the benefits outweigh the risks? New England Journal of Medicine, 335, 659–660CrossRefGoogle Scholar
  48. Manson, J.E. and G.A. Faich (1996b), Conflicts of interest – editorialists respond, New England Journal of Medicine, 335, 1064–1065CrossRefGoogle Scholar
  49. Manson, J.E., W.C. Willett, M.J. Stampfer et al. (1995), Body weight and mortality among women, New England Journal of Medicine, 333, 677–685CrossRefGoogle Scholar
  50. Mokdad, A.H., J.S. Marks, D.F. Stroup et al. (2004), Actual causes of death in the United States, 2000, JAMA, 291, 1238–1245CrossRefGoogle Scholar
  51. NIH (1994), National institutes of health national task force on the prevention and treatment of obesity, weight cycling, Journal of the American Medical Association 270, 8, 1196–1202Google Scholar
  52. NIH (1996), National institutes of health national task force on the prevention and treatment of obesity, long-term pharmacotherapy in the management of obesity, Journal of the American Medical Association, 276, 23, 1907–1915CrossRefGoogle Scholar
  53. Saguy, A.C. and K.W. Riley (2005), Weighing both sides: Morality, mortality, and framing contests over obesity, Journal of Health Politics, Policy and Law, 30, 869–921CrossRefGoogle Scholar
  54. Scott, D. (2003), Science and the consequences of mistrust: Lessons from recent GM controversies, Journal of Agricultural and Environmental Ethics, 16, 569–582CrossRefGoogle Scholar
  55. Shell, E.R. (2002), The Hungry Gene: The Science of Fat and the Future of Thin. London: Atlantic BooksGoogle Scholar
  56. Sismondo, S. (2004), Pharmaceutical maneuvers, Social Studies of Science, 34, 2, 149–159CrossRefGoogle Scholar
  57. Stein, R. (2003), Is obesity a disease? Insurance, drug access may hinge on answer, Washington Post Google Scholar
  58. Stein, R. and C. Connolly. (2004), Medicare changes policy on obesity: Some treatments may be covered, Washington Post Google Scholar
  59. Stenson, J. (2003), Can you be both fit and fat? Even with exercise, size may still matter, MSNBC.com. http://www.msnbc.msn.com/id/3076623 [Accessed July 2005]
  60. Stinchcombe, A.L. (2001.), Universities and the Communism of Knowledge as the Core of the World Information Economy .http://www.sase.org/con2001/papers/stinchcombe.arthur.pdf [Accessed July 2005]
  61. Tannahill, A. (1992), Epidemiology and health promotion: A common understanding. In: R. Bunton, and G. Macdonald (eds), Health Promotion: Disciplines and Diversity. New York, NY: Routledge, pp. 86–107Google Scholar
  62. Troiano, R.P., E.A. Frongillo, Jr., J. Sobal and D.A. Levitsky (1996), The relationship between body weight and mortality: A quantitative analysis of combined information from existing studies, International Journal of Obesity, 20, 63–75Google Scholar
  63. van Kolfschooten, F (2002), Conflicts of interest: Can you believe what you read? Nature, 416, 360–363CrossRefGoogle Scholar
  64. Visser, M. (1995), Dik voor mekaar: Handreiking voor een breed draagvlak. Haarlem: De ToortsGoogle Scholar
  65. Wann, M. (1999), FAT! SO?: Because You Don’t Have to Apologize for Your Size. Berkley, CA: Ten Speed PressGoogle Scholar
  66. Wolf, A.M. and G.A. Colditz. (1998), Current estimates of the economic costs of obesity in the United States, Obesity Research, 6, 2, 97–106Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  1. 1.Wageningen UniversityWageningenThe Netherlands

Personalised recommendations